Resistance of Pseudomonas aeruginosa to antibiotics;Oporność Pseudomonas aeruginosa na antybiotyki

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 1300-1311

  Wolska, Katarzyna ^a   Kot, Barbara ^a   Piechota, Małgorzata ^a   Frankowska, Aneta ^a  

^a SIEDLCE UNIVERSITY OF NATURAL SCIENCES AND HUMANITIES   (Poland)

Author keywords

Aminoglycosides; Beta lactams; Pseudomonas aeruginosa; Quinolone; Resistance

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG EFFECT; HUMAN; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84892606743     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1080803     Document Type: Article

References (95)

1. Aires J. R., Kohler T., Nikaido H., Plesiat P.: Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother., 1999;43:2624-2628
2. Akasaka T., Tanaka M., Yamagushi A., Sato K.: Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanizm of fluoroquinolone resistance. Antimicrob. Agents Chemother., 2001;45:2263-2268
3. Algun U., Arisoy A., Gunduz T., Ozbakkaloglu B.: The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics. Ind. J. Med. Microbiol., 2004;22:112-114
4. Arakawa Y., Shibata N., Shibayama K., Kurosawa H., Yagi T., Fujiwara H., Goto M.: Convenient test for screening metallo-β-lactamaseproducing Gram-negative bacteria by using thiol compounds. J. Clin. Microbiol., 2000;38:40-43
5. Bagge N., Ciofu O., Hentzer M., Campbell J. I., Givskov M., Hoiby N.: Constitutive high expression of chromosomal β-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob. Agents Chemother., 2002;46:3406-3411
6. Bert F., Branger C., Lambert-Zechovsky N.: Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother., 2002;50:11-18
7. Bradford P. A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev., 2001;14:933-951
8. Bush K., Jacoby G. A., Medeiros A. A.: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 1995;39:1211-1233
9. Canton R., Cobos N., de Gracia J., Baquero F., Honorato J., Gartner S., Alvarez A., Salcedo A., Oliver A., Garcia-Quetglas E.: Antimicrobial therapy for pulmonary pathogenic colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin. Microbiol. Infect., 2005;11:690-703
10. Cao W., Yao D., Zheng R.: Resistance by hypermutable Pseudomonas aeruginosa and beta-lactamases production. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2009;34:54-58
11. Castanheira M., Toleman M. A., Jones R. N., Schmidt F. J., Walsh T. R.: Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother., 2004;48:4654-4661
12. Cavallo J. D., Plesiat P., Couetdic G., Leblanc F., Fabre R.: Mechanisms of β-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997). J. Antimicrob. Chemother., 2002;50:1039-1043
13. Chen J., Su Z., Liu Y., Wang S., Dai X., Li Y., Peng S., Shao Q., Zhang H., Wen P., Yu J., Huang X., Xu H.: Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang. China Int. J. Infect. Dis., 2009;13:717-721
14. Chopra I., O'Neill A. J., Adams J., Paterson D. L.: Coproduction of novel 16S rRNA methylase and metallo-β-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil. Antimicrob. Agents Chemother., 2006;51:852-856
15. Danel F., Hall L. M., Duke B., Gur D., Livermoore D. M.: OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1999;43:1362-1366
16. Deplano A., Denis O., Poirel L., Hocquet D., Nonhoff C., Byl B., Nordmann P., Vincent J. L., Struelens M. J.: Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J. Clin. Microbiol., 2005;43:1198-1204
17. Doi Y., de Olivera Garcia D., Adams J., Paterson D. L.: Coproduction of novel 16S rRNA methylase and metallo-β-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil. Antimicrob. Agents Chemother., 2006;51:852-856
18. Dong F., Xu X. W., Song W. Q., Lü P., Yu S. J., Yang Y. H., Shen X. Z.: Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a peadiatric clinic in China. Chin. Med. J., 2008;121:1611-1616
19. Dubois V., Arpin C., Dupart V., Scavelli A., Coulange L., André C., Fischer I., Grobost F., Brochet J. P., Lagrange I., Dutilh B., Jullin J., Noury P., Larribet G., Quentin C.: β-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J. Antimicrob. Chemother., 2008;62:316-323
20. Dubois V., Poirel L., Marie C., Arpin C., Nordmann P., Quentin C.: Molecular characterization of a novel class 1 integron containing bla (GES-1) and a fused product of aac3-Ib/aac6́-Ib? gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2002;46:638-645
21. Dzierżanowska D.: Antybiotykoterapia praktyczna. Wyd. III, Alfa-Medica Press Bielsko-Biała, 2001
22. Falagas M. E., Kasiakou S. K.: Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis., 2005;40:1333-1341
23. Falagas M. E., Koletsi P. K., Bliziotis I. A.: The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumanii and Pseudomonas aeruginosa. J. Med. Microbiol., 2006;55:1619-1629
24. Fiett J., Baraniak A., Mrówka A., Fleischer M., Drulis-Kawa Z., Naumiuk Ł., Samet A., Hryniewicz W., Gniadkowski M.: Molecular epidemiology of acquired-metallo-β-lactamase-producing bactaeria in Poland. Antimicrob. Agents Chemother., 2006;50:880-886
25. Flamm R. K., Weaver M. K., Thornsberry C., Jones M. E., Karlovsky J. A., Sahm D. E.: Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob. Agents Chemother., 2004;48:2431-2436
26. Gales A. C., Menezes L. C., Silbert S., Sader H. S.: Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J. Antimicrob. Chemother., 2003;52:699-702
27. Ge C., Wei Z., Jiang Y., Shen P., Yu Y., Li L.: Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China. Antimicrob. Chemother., 2011;66:1184-1186
28. Gilligan P. H.: Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev., 1991;4:35-51
29. Girlich D., Naas T., Leelaporn A., Poirel L., Fennewald M., Nordmann P.: Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum β-lactamase in Pseudomonas aeruginosa in Thailand. Clin. Infect. Dis., 2002;34:603-611
30. Giwercman B., Lambert P. A., Rosdahl V. T., Shand G. H., Hoiby N.: Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in vivo selection of stable partially derepressed beta-lactamase producing strains. J. Antimicrob. Chemother., 1990;26:247-259
31. Gutierrez O., Juan C., Perez J. L., Oliver A.: Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob. Agents Chemother., 2004;48:3573-3575
32. Hauser A. R., Sriram P.: Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad. Med., 2005;117:41-48
33. Hedges R. W., Matthew M.: Acquisition by Escherichia coli of plasmid-borne beta lactamases normally confined to Pseudomonas spp. Plasmid, 1979;2:269-278
34. Henrichfreise B., Wiegand I., Pfister W., Wiedemann B.: Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob. Agents Chemother., 2007;51:4062-4070
35. Hocquet D., Nordmann P., El Garch F., Cabanne L., Plesiat P.: Involvement of the MexXY-OprM efflux system in emergence of cefpime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2006;50:1347-1351
36. Hocquet D., Vogne C., El Garch F., Vejux A., Gotoh N., Lee A., Lomovskaya O., Plesiat P.: MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother., 2003;47:1371-1375
37. Islam S., Oh H., Jalal S., Karpati F., Ciofu O., Hoiby N., Wretlind B.: Chromosomal mechanisms of aminoglycosides resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin. Microbiol. Infect., 2009;15:60-66
38. Jacoby G. A.: Resistance plasmids of Pseudomonas aeruginosa. W: The Bacteria, red. I. C. Gunsalus, J. R. Sokatch, L. N. Ornston, Academic Press, Orlando, 1986, s. 265-293
39. Jalal S., Ciofu O., Hoiby N., Gotoh N., Wretlind B.: Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother., 2000;44:710-712
40. Jarmuła A, Obła̧k E., Wawrzycka D., Gutowicz J.: Oporność wielolekowa zwia̧zana z aktywnym usuwaniem leków z komórek drobnoustrojów Efflux-mediated antimicrobial multidrug resistance. Postȩpy Hig. Med. Dośw., 2011;65:216-227
41. Jo J. T., Brinkman F. S., Hancock R. E.: Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins. Antimicrob. Agents Chemother., 2003;47:1101-1111
42. Join-Lambert O. F., Michea-Hamzehpour M., Kohler T., Chau F., Faurisson F., Dautrey S., Vissuzaine C., Carbon C., Pechere J.: Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob. Agents Chemother., 2001;45:571-576
43. Jovcic B., Lepsanovic Z., Suljagic V., Rackov G., Begovic L., Kojic M.: Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob. Agents Chemother., 2011;55:3929-3931
44. Juan C., Macia M. D., Gutierrez O., Vidal C., Perez J. L., Oliver A.: Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob. Agents Chemother., 2005;49:4733-4738
45. Juan C., Moya B., Perez J. L., Oliver A.: Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother., 2006;50:1780-1787
46. Karlovsky J. A., Draghi D. C., Jones M. E., Thornsberry C., Friedland I. R., Sahm D. F.: Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob. Agents Chemother., 2003;47:1681-1688
47. Laraki N., Galleni M., Thamm I., Riccio M. L., Amicosante G., Frere J. M., Rossolini G. M.: Structure of In31, a blaIMP containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob. Agents Chemother., 1999;43:890-901
48. Laudy A. E.: Karbapenemazy - enzymy moga̧ce hydrolizować szerokie spectrum β-laktamów. Zakażenia, 2003;4:32-38
49. Laughlin R. S., Mush M. W., Hollbrook C. J., Rocha M., Chang E. B., Alverdy J. C.: The key role of Pseudomonas aeruginosa PA-I lectin experimental gut-derived sepsis. Ann. Surg., 2000;232:133-142
50. Lauretti L., Riccio M. L., Mazzariol A., Cornaglia G., Amicosante G., Fontana R., Rossolini G. M.: Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother., 1999;43:1584-1590
51. Lee J. K., Lee Y. S., Park Y. K., Kim B. S.: Alterations in the GyrA and Gyr B subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents, 2005;25:290-295
52. Liao X., Hancock R. E.: Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3. Antimicrob. Agents Chemother., 1995;39:1871-1874
53. Livermoore D. M.: Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis., 2002;34:634-640
54. Llanes C., Neuwirth C., El Garch F., Hocquet D., Plesiat P.: Genetic analysis of a multiresistant strain of Pseudomonas aeruginosa producing PER-1 β-lactamase. Clin. Microbiol. Infect., 2006;12:270-278
55. Luzarro F., Mentengoli E., Perilli M., Lombardi G., Orlandi V., Orsatti A., Amicosante G., Rossolini G. M., Toniolo A.: Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbiol., 2001;39:1865-1870
56. Macia M. D., Blanquer D., Togores B., Sauleda J., Perez J. L., Oliver A.: Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother., 2005;49, 3382-3386
57. Maltezou H. C.: Metallo-β-lactamases in Gram-negative bacteria: introducing the era of panresistance? Int. J. Antimicrob. Agents, 2008;33:e1-e7
58. McGowan J. E. Jr.: Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am. J. Infect. Control, 2006;34:S29-S37
59. Mugnier P., Dubrous P., Casin I., Arlet G., Collatz E.: A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1996;40:2488-2493
60. Munck A., Bonacorsi S., Mariani-Kurkdjian P., Lebourgeois M., Gerardin M., Brahimi N., Navarro J., Bingen E.: Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr. Pulmonol., 2001;32:288-292
61. Neonakis I. K., Scoulica E. V., Dimitriou S. K., Gikas A. I., Tselentis Y. J.: Molecular epidemiology of extended-spectrum beta-lactamases produced by clinical isolates in a university hospital in Greece: detection of SHV-5 in Pseudomonas aeruginosa and prevalence of SHV-12. Microb. Drug Resist., 2003;9:161-165
62. Normark B. H., Normark S.: Evolution and spread of antibiotic resistance. J. Intern. Med., 2002;252:91-106
63. Nowak P., Targosz A., Budak A., Oleksiak D., Gȩza G., Skałkowska M.: Wrażliwość na chemioterapeutyki oraz wystȩpowanie metalo-β-laktamaz u szpitalnych szczepów Pseudomonas aeruginosa. Med. Dośw. Mikrobiol., 2006;58:231-237
64. Obritsch M. D., Fish D. N., MacLaren R., Jung R.: National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care units patients from 1993 to 2002. Antimicrob. Agents Chemother., 2004;48:4606-4610
65. Ochs M. M., McCusker M. P., Bains M., Hancock R. E.: Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob. Agents Chemother., 1999;43:1085-1090
66. Oliver A., Canton R., Campo P., Baquero F., Blazquez J.: High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science, 2000;288:1251-1254
67. Pagani L., Colinon C, Migliavacca R., Labonia M., Docquier J. D., Nucleo E., Spalla M., Li Bergoli M., Rossolini G. M.: Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta- lactamase. J. Clin. Microbiol., 2005;43:3824-3828
68. Pagniez G., Radice M., Cuirolo A., Rodriguez O., Rodriguez H, Vay C., Famiglietti A., Gutkind G.: Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at an university hospital of Buenos Aires City. Rev. Argent. Microbiol., 2006;38:33-37
69. Patzer J., Dzierżanowska D.: The incidence of serotype O12 and multiresistance amongst Pseudomonas aeruginosa clinical isolates. J. Antimicrob. Chemother., 1997;34:165-170
70. Patzer J., Toleman M. A., Deshpande L. M., Kaminska W., Dzierżanowska D., Bennet P. M. Jones R. N., Walsh T. R.: Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother., 2004;53:451-456
71. Poirel L., Brinas L., Fortineau N., Nordmann P.: Integron-encoded GES-type extended-spectrum β-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2005;49:3593-3597
72. Poirel L., Brinas L., Verlinde A., Ide L., Nordmann P.: BEL-1, a novel clavulanic acid-inhibited extended-spectrum β-lactamase, and the class 1 integron In 120 in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2005;49:3743-3748
73. Poirel L., Nordmann P.: Acquied carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr. Pharm. Biotechnol., 2002;3:117-127
74. Poirel L., Nordmann P., Lagrutta E., Cleary T., Munoz-Price L. S.: Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob Agents Chemother., 2010;54:3072
75. Poirel L., Weldhagen G. F., De Champs C, Nordmann P.: A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa. J. Antimicrob. Chemother., 2002;49:561-565
76. Poole K.: Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2005;49:479-487
77. Quale J., Bratu S., Gupta J., Landman D.: Interplay of efflux system ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother., 2006;50:1633-1641
78. Riccio M. L., Docquier J. D., Dell Amico E., Luzzaro F., Amicosante G., Rossolini G. M.: Novel 3-N-aminoglycoside acetyltransferase gene, aac (3)-Ic, from Pseudomonas aeruginosa integron. Antimicrob. Agents Chemother., 2003;47:1746-1748
79. Rusiecka-Ziółkowska J., Fleischer M., Staroszczyk J.: Właściwości immunologiczne Gram-ujemnych pałeczek Pseudomonas aeruginosa. Postȩpy Hig. Med. Dośw., 2007;61:95-98
80. Sacha P., Żórawski M., Hauschild T., Wieczorek P., Jaworowska J., Jakoniuk P., Tryniszewska E.: The presence of blaIMP genes on plasmids DNA isolated from multidrug-resistant Pseudomonas aeruginosa strains at University Hospital in B ialystok (Poland) - first report. Folia Histochem. Cytobiol., 2007;45:405-408
81. Sekiguchi J., Asagi T., Miyoshi-Akiyama T., Fujino T., Kobayashi I., Morita K., Kikuschi Y., Kuratsuji T., Kirikae T.: Multidrug-resistant Pseudomonas aeruginosa strain that caused in a neurosurgery ward and its aac (6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob. Agents Chemother., 2005;49:3734-3742
82. Shaw K. J., Cramer C. A., Rizzo M., Mierzwa R., Gewain K., Miller G. H., Hare R. S.: Isolation, characterization, and DNA sequence analysis of an aac (6?)-II gene from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1989;33:2052-2062
83. Shaw K. J., Hare R. S., Sabatelli F. J., Rizzo M., Cramer C. A., Naples L., Kocsi S., Munayyer H., Mann P., Miller G. H., Verbist L., van Landuyt H., Glupczynski Y., Catalano M., Woloj M.: Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob. Agents Chemother., 1991;35, 2253-2261
84. Stokes H. W., Hall R. M.: A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol., 1989;3:1669-1683
85. Strateva T., Yordanov D.: Pseudomonas aeruginosa - a phenomen of bacterial resistance. J. Med. Microbiol., 2009;58:1133-1148
86. Toleman M. A., Biedenbach D., Bennett D., Jones R. N., Walsh T. R.: Genetic characterization of a novel metallo-beta-lactamase gene, bla-IMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J. Antimicrob. Chemother., 2003;52:583-590
87. Torres C., Perlin M. H., Baquero F., Lerner D. L., Lerner S. A.: High-level amikacin resistance in Pseudomonas aeruginosa assiociated with a 3́-phosphotransferase with high affinity for amikacin. Int. J. Antimicrob. Agents., 2000;15:257-263
88. Tsakris A., Pournaras S., Woodford N., Palepou M. F., Babini G. S., Douboyas J., Livermore D. M.: Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol., 2000;38:1290-1292
89. Villegas M. V., Lolans K., Correa A., Kattan J. N., Lopez J. A., Quinn J. P., Colombian Nosocomial Resistance Study Group: First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother., 2007;51:1553-1555
90. Wasa̧żnik A., Grinholc M., Bielawski K. P.: Czynne usuwanie leku z komórki jako jeden z mechanizmów oporności bakterii na środki przeciwdrobnoustrojowe i metody jego zwalczania. Postȩpy Hig. Med. Dośw., 2009;63:123-133
91. Watanabe M., Iyobe S., Inoue M., Mitsuhashi S.: Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1991;35:147-151
92. Wolter D. J., Hanson N. D., Lister P. D.: AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump. Antimicrob. Agents Chemother., 2005;49:4763-4766
93. Yamane K., Doi Y., Yokoyama K., Yagi T., Kurokawa H., Shibata N., Shibayama K., Kato H., Arakawa Y.: Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother., 2004;48:2069-2074
94. Yan J. J., Tsai S. H., Chuang C. L., Wu J. J.: OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. J. Microbiol. Immunol. Infect., 2006;39:130-134
95. Yoneyama H., Nakae T.: Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1993;37:2385-2390